Status:
UNKNOWN
Extended-spectrum β-lactamase -Producing Enterobacteriaceae (ESBL) Vertical Transmission in Women With Preterm Labor Versus Those in Term Pregnancy
Lead Sponsor:
Western Galilee Hospital-Nahariya
Conditions:
Preterm Labor
Eligibility:
FEMALE
18-45 years
Brief Summary
The aims of the study are to evaluate the rate of ESBL-producing Enterobacteriaceae colonization among women in preterm labor and term labor, the incidence of maternal vertical transmission of ESBL, a...
Detailed Description
Preterm delivery occurs before 37 weeks of gestation. Worldwide the preterm birth rate is estimated to be about 11% and in Israel the preterm birth rate is approximately 7% (1, 2). Preterm birth is th...
Eligibility Criteria
Inclusion
- Preterm delivery \<37 weeks of gestation
- term delivery \> 37 weeks of gestation
Exclusion
- Unknown gestational age
Key Trial Info
Start Date :
April 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03251885
Start Date
April 12 2017
End Date
June 1 2022
Last Update
March 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Galil Medical Center
Nahariya, Israel